ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 917

$541K Total Retail Price of All Prescriptions

Rank: 95 out of 917

647 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 647 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,226 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 569 460 1 1
OMEPRAZOLE 545 443 2 4
LEVOTHYROXINE SODIUM 484 400 3 3
AMLODIPINE BESYLATE 373 305 4 5
SIMVASTATIN 368 324 5 2
LOVASTATIN 339 308 6 19
HYDROCODONE-ACETAMINOPHEN 301 177 S3 7 6
METFORMIN HCL 287 242 8 8
FUROSEMIDE 284 213 9 7
CITALOPRAM HBR 240 199 10 15
WARFARIN SODIUM 240 213 10 10
HYDROCHLOROTHIAZIDE 223 190 12 9
ATENOLOL 222 208 13 12
METOPROLOL TARTRATE 220 194 14 11
LOSARTAN POTASSIUM 219 202 15 13
TRAZODONE HCL 179 117 16 22
SERTRALINE HCL 175 118 17 24
METOPROLOL SUCCINATE 164 142 18 18
TRAMADOL HCL 156 120 19 28
GABAPENTIN 150 106 20 17
PROAIR HFA 145 94 21 35
GLIPIZIDE 145 129 21 40
ATORVASTATIN CALCIUM 144 122 23 14
POTASSIUM CHLORIDE 129 110 24 16
PRAVASTATIN SODIUM 110 83 25 20
MELOXICAM 100 94 26 53
LANTUS SOLOSTAR 100 72 26 63
ALENDRONATE SODIUM 99 91 28 23
FLUTICASONE PROPIONATE 88 67 29 26
HYDROXYZINE HCL 80 43 R 30 266
TAMSULOSIN HCL 78 77 31 25
CRESTOR 76 76 32 30
ZOLPIDEM TARTRATE 73 60 33 21
INSULIN SYRINGE 73 55 33 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 64 33 42
ALLOPURINOL 73 66 33 31
FLUOXETINE HCL 70 53 37 38
BUPROPION HCL SR 69 39 38 101
IBUPROFEN 69 42 38 97
TRIAMCINOLONE ACETONIDE 68 64 40 96
ADVAIR DISKUS 67 61 41 47
LANTUS 63 42 42 37
DIGOXIN 63 63 42 41
CLONIDINE HCL 62 51 44 85
PAROXETINE HCL 60 56 45 57
QUETIAPINE FUMARATE 58 43 46 52
SPIRIVA 57 39 47 45
BUSPIRONE HCL 55 31 48 160
NIFEDIPINE ER 54 54 49 139
FENOFIBRATE 54 44 49 73
PANTOPRAZOLE SODIUM 53 52 51 44
JANUVIA 52 52 52 81
PEN NEEDLE 51 32 53 99
NOVOLOG FLEXPEN 50 35 54 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.